Genmab CEO: Three products may turn into five this year

Normally, it takes ten months for a marketing authorization to be processed in the US. Genmab hopes for an accelerated process, so the firm can get approval for two new products this year.
Photo: Tuala Hjarnø / Genmab / PR
Photo: Tuala Hjarnø / Genmab / PR
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN

Genmab's three winning horses may very well turn into five in the course of 2021.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading